Reversal of J&J $72m verdict over talc cancer risks
            
        
            
        
        
        
            Johnson & Johnson has won the reversal of a $72m (€61.3m) verdict in the US in favour of the family of a woman whose death from ovarian cancer they claimed stemmed from her use of the company's talc-based products like Johnson's Baby Powder.
        
        
        
        
            
                Business
                 • 18 Oct 17